Design and Characterization of R1626, A Prodrug of the HCV Replication Inhibitor R1479 (4′-Azidocytidine) With Enhanced Oral Bioavailability
Klaus Klumpp, David Smith, Michael Brandl, Tom Alfredson, Keshab Sarma, Mark Smith, Isabel Najera, Wen-Rong Jiang, Sophie Le Pogam, Vincent Leveque, Han Ma, Yaping Tu, Rebecca Chan, Chiao-Wen Chen, XiVolume:
74
Year:
2007
Language:
english
Pages:
1
DOI:
10.1016/j.antiviral.2007.01.029
File:
PDF, 65 KB
english, 2007